Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target

Kocks JW, Tuinenga MG, Uil SM, Van den Berg JW, Ståhl E, Van Der Molen T. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7:1–8.

Article  Google Scholar 

Kakavas S, Kotsiou OS, Perlikos F, Mermiri M, Mavrovounis G, Gourgoulianis K, Pantazopoulos I. Pulmonary function testing in COPD: looking beyond the curtain of FEV1. NPJ Prim Care Respir Med. 2021;31(1):23.

Article  PubMed  PubMed Central  Google Scholar 

Kellerer C, Jörres RA, Schneider A, Alter P, Kauczor HU, Jobst B, Biederer J, Bals R, Watz H, Behr J, Kauffmann-Guerrero D. Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET. Respir Res. 2021;22:1–1.

Article  Google Scholar 

Eberlein M, Schmidt GA, Brower RG. Chest wall strapping. An old physiology experiment with new relevance to small airways diseases. Ann Am Thorac Soc. 2014;11(8):1258–66.

Article  PubMed  PubMed Central  Google Scholar 

Janssens W, Liu Y, Liu D, Kesten S, Tashkin DP, Celli BR, Decramer M. Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med. 2013;107(9):1409–16.

Article  CAS  PubMed  Google Scholar 

Lipson DA, Barnacle H, Birk R, Brealey N, Locantore N, Lomas DA, Ludwig-Sengpiel A, Mohindra R, Tabberer M, Zhu CQ, Pascoe SJ. FULFIL trial: once-daily triple therapy for patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196(4):438–46.

Article  CAS  PubMed  Google Scholar 

Ramírez-Venegas A, Velázquez-Uncal M, Aranda-Chávez A, Guzmán-Bouilloud NE, Mayar-Maya ME, Pérez Lara-Albisua JL, Hernandez-Zenteno RD, Flores-Trujillo F, Sansores RH. Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial. Int J Chron Obstruct Pulmon Dis. 2019;6:1753–62.

Article  Google Scholar 

Juan CA, Pérez de la Lastra JM, Plou FJ, Pérez-Lebeña E. The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. Int J Mol Sci. 2021;22(9):4642.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sunnetcioglu A, Alp HH, Sertogullarından B, Balaharoglu R, Gunbatar H. Evaluation of oxidative damage and antioxidant mechanisms in COPD, lung cancer, and obstructive sleep apnea syndrome. Respir Care. 2016;61(2):205–11.

Article  PubMed  Google Scholar 

Dailah HG. Therapeutic potential of small molecules targeting oxidative stress in the treatment of chronic obstructive pulmonary disease (COPD): a comprehensive review. Molecules. 2022;27(17):5542.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dekany M, Nemeskeri V, Györe I, Harbula I, Malomsoki J, Pucsok J. Antioxidant status of interval-trained athletes in various sports. Int J Sports Med. 2005;30:112–6.

Google Scholar 

Heijink IH, Brandenburg SM, Postma DS, van Oosterhout AJ. Cigarette smoke impairs airway epithelial barrier function and cell–cell contact recovery. Eur Respir J. 2012;39(2):419–28.

Article  CAS  PubMed  Google Scholar 

Dal Negro RW, Visconti M, Turco P. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: results of a double blind, placebo-controlled trial. Pulm Pharmacol Ther. 2015;1(33):47–51.

Article  Google Scholar 

Singh S, Verma SK, Kumar S, Ahmad MK, Nischal A, Singh SK, Dixit RK. Evaluation of oxidative stress and antioxidant status in chronic obstructive pulmonary disease. Scand J Immunol. 2017;85(2):130–7.

Article  CAS  PubMed  Google Scholar 

Agacdiken A, Basyigit I, Özden M, Yildiz F, Ural D, Maral H, Boyaci H, Ilgazli A, Komsuoglu B. The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD. Respirology. 2004;9(1):38–42.

Article  PubMed  Google Scholar 

Chillappagari S, Preuss J, Licht S, Müller C, Mahavadi P, Sarode G, Vogelmeier C, Guenther A, Nahrlich L, Rubin BK, Henke MO. Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction. Respir Res. 2015;16(1):1–9.

Article  CAS  Google Scholar 

Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011;3(12): a005058.

Article  PubMed  PubMed Central  Google Scholar 

Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respir Med. 2011;105(8):1129–39.

Article  PubMed  Google Scholar 

Geraghty P, Rogan MP, Greene CM, Brantly ML, O’Neill SJ, Taggart CC, McElvaney NG. Alpha-1-antitrypsin aerosolized augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro. Thorax. 2008;63(7):621–6.

Article  CAS  PubMed  Google Scholar 

Ghosh A, Coakley RD, Ghio AJ, Muhlebach MS, Esther CR Jr, Alexis NE, Tarran R. Chronic e-cigarette use increases neutrophil elastase and matrix metalloprotease levels in the lung. Am J Respir Crit Care Med. 2019;200(11):1392–401.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):1–9.

CAS  Google Scholar 

Babkina II, Sergeeva SP, Gorbacheva LR. The role of NF-κB in neuroinflammation. Neurochem J. 2021;15(2):114–28.

Article  CAS  Google Scholar 

Sun SC. The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17(9):545–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Milnerowicz H, Ściskalska M, Dul M. Molecular mechanisms of the impact of smoke-oxidants. Exp Toxicol Pathol. 2015;67(7–8):377–82.

Article  CAS  PubMed  Google Scholar 

Akata K, Yamasaki K, Leitao Filho FS, Yang CX, Takiguchi H, Sahin B, Whalen BA, Yang CW, Leung JM, Sin DD, van Eeden SF. Abundance of non-polarized lung macrophages with poor phagocytic function in Chronic obstructive pulmonary disease (COPD). Biomedicines. 2020;8(10):398.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ando M, Magi S, Seki M, Suzuki Y, Kasukawa T, Lefaudeux D, Hoffmann A, Okada M. IκBα is required for full transcriptional induction of some NFκB-regulated genes in response to TNF in MCF-7 cells. NPJ Syst Biol Appl. 2021;7(1):42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lennikov A, Mirabelli P, Mukwaya A, Schaupper M, Thangavelu M, Lachota M, Lagali N, et al. Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis. Angiogenesis. 2018;21(2):267–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen KK, Minakuchi M, Wuputra K, Ku CC, Pan JB, Kuo KK, Yokoyama KK, et al. Redox control in the pathophysiology of influenza virus infection. BMC Microbiol. 2020;20(1):1–22.

Article  CAS  Google Scholar 

Mayer IA, Arteaga CL. The PI3K/AKT pathway as a target for cancer treatment. Annu Rev Med. 2016;67:11–28.

Article  CAS  PubMed  Google Scholar 

Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Tang N, Hadden TJ, Rishi AK. Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta Mol Cell Res. 2011;2011(11):1978–86.

Article  Google Scholar 

Liu H, Yin T, Yan W, Si R, Wang B, Chen M, Li F, Wang Q, Tao L. Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2017;19:1781–91.

Article  Google Scholar 

Baker JR, Vuppusetty C, Colley T, Papaioannou AI, Fenwick P, Donnelly L, Barnes PJ, et al. Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells. Sci Rep. 2016;6(1):1–13.

Article  CAS  Google Scholar 

Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871.

Article  PubMed  PubMed Central  Google Scholar 

Gwynne M, Mounsey A. Would this long-acting bronchodilator be better for your patient? J Fam Pract. 2012;61(2):94.

PubMed  PubMed Central  Google Scholar 

Jones RL, Noble PB, Elliot JG, James AL. Airway remodelling in COPD: it’s not asthma! Respirology. 2016;21(8):1347–56.

Article  PubMed  Google Scholar 

LaPreze J. Management of stable chronic obstructive pulmonary disease. US Pharm. 2013;38(7):43–6.

Google Scholar 

Tretter V, Hochreiter B, Zach ML, Krenn K, Klein KU. Understanding cellular redox homeostasis: a challenge for precision medicine. Int J Mol Sci. 2021;23(1):106.

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif